Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ellenberger

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Multiple Sclerosis and Related Disorders|January 29, 2022
Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in GermanyJakob Holstiege, Manas K Akmatov, Kerstin Klimke, et al.
Neurology and Therapy|January 12, 2022
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS RegistryNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Circulation|July 24, 2013
Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathologyThomas H Fischer, Jonas Herting, Theodor Tirilomis, et al.
The Lancet Regional Health. Europe|September 12, 2022
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational studyNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Cardiovascular Research|June 23, 2018
Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heartNataliya Dybkova, Shakil Ahmad, Steffen Pabel, et al.
Genes, Chromosomes & Cancer|April 26, 2014
Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic studyPhilipp Ströbel, Andreas Zettl, Konstantin Shilo, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Multiple sclerosis registries in Europe - results of a systematic surveyPeter Flachenecker, Karoline Buckow, Maura Pugliatti, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Multiple Sclerosis and Related Disorders|January 29, 2022
Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in GermanyJakob Holstiege, Manas K Akmatov, Kerstin Klimke, et al.
Neurology and Therapy|January 12, 2022
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS RegistryNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Circulation|July 24, 2013
Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathologyThomas H Fischer, Jonas Herting, Theodor Tirilomis, et al.
The Lancet Regional Health. Europe|September 12, 2022
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational studyNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Cardiovascular Research|June 23, 2018
Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heartNataliya Dybkova, Shakil Ahmad, Steffen Pabel, et al.
Genes, Chromosomes & Cancer|April 26, 2014
Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic studyPhilipp Ströbel, Andreas Zettl, Konstantin Shilo, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Multiple sclerosis registries in Europe - results of a systematic surveyPeter Flachenecker, Karoline Buckow, Maura Pugliatti, et al.
Pageof 5